Research Calls
- Upgrades:
- Dream Finders Homes (DFH) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $12
- FREYR Battery (FREY) upgraded to Buy from Neutral at Goldman; tgt raised to $19
- Kosmos Energy (KOS) upgraded to Buy from Hold at Berenberg; tgt raised to $8.50
- Stride (LRN) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $45
- Verve Therapeutics (VERV) upgraded to Buy from Hold at Stifel; tgt raised to $56
- Downgrades:
- Edgewise Therapeutics (EWTX) downgraded to Sell from Neutral at Goldman; tgt $5
- GDS Holdings (GDS) downgraded to Hold from Buy at Deutsche Bank; tgt $32.80
- KB Home (KBH) downgraded to Neutral from Buy at BofA Securities; tgt $34
- Krystal Biotech (KRYS) downgraded to Neutral from Buy at Goldman; tgt $74
- La-Z-Boy (LZB) downgraded to Mkt Perform from Outperform at Raymond James
- Lennar (LEN) downgraded to Underperform from Neutral at BofA Securities; tgt $82
- Magenta Therapeutics (MGTA) downgraded to Neutral from Buy at Goldman; tgt $2
- Toll Brothers (TOL) downgraded to Neutral from Buy at BofA Securities; tgt $49
- Others:
- Actinum Pharma (ATNM) initiated with a Buy at B. Riley Securities; tgt $16
- Adaptive Biotechnologies (ADPT) initiated with an Underperform at Credit Suisse; tgt $8
- Agilent (A) initiated with an Outperform at Credit Suisse; tgt $165
- Avantor (AVTR) initiated with a Neutral at Credit Suisse; tgt $32
- Avidbank Holdings (AVBH) initiated with an Overweight at Piper Sandler; tgt $24
- Bio-Rad Labs (BIO) initiated with an Outperform at Credit Suisse; tgt $715
- Bio-Techne (TECH) initiated with an Outperform at Credit Suisse; tgt $465
- Certara (CERT) initiated with an Outperform at Credit Suisse; tgt $22
- ChampionX (CHX) initiated with a Buy at The Benchmark Company; tgt $32
- Charles River (CRL) initiated with an Outperform at Credit Suisse; tgt $285
- Concert Pharmaceuticals (CNCE) initiated with a Buy at JonesTrading; tgt $17
- Danaher (DHR) initiated with an Outperform at Credit Suisse; tgt $340
- Enhabit Inc. (EHAB) initiated with a Neutral at Credit Suisse; tgt $19
- Exact Sciences (EXAS) initiated with an Outperform at Credit Suisse; tgt $55
- Fulgent Genetics (FLGT) initiated with an Outperform at Credit Suisse; tgt $65
- Guardant Health (GH) initiated with an Outperform at Credit Suisse; tgt $80
- ICON plc (ICLR) initiated with a Neutral at Credit Suisse; tgt $260
- Illumina (ILMN) initiated with a Neutral at Credit Suisse; tgt $230
- IQVIA (IQV) initiated with an Outperform at Credit Suisse; tgt $300
- Impel Pharmaceuticals (IMPL) initiated with a Buy at JonesTrading; tgt $26
- Invitae (NVTA) initiated with an Underperform at Credit Suisse; tgt $1
- Kimbell Royalty Partners (KRP) initiated with a Buy at Citigroup; tgt $24
- Kinetik (KNTK) initiated with an Equal-Weight at Morgan Stanley; tgt $46
- Lion Electric (LEV) initiated with a Sell at Veritas; tgt $2.50
- Maravai Life Sciences (MRVI) initiated with an Outperform at Credit Suisse; tgt $34
- MoonLake Immunotherapeutics (MLTX) initiated with an Outperform at SVB Leerink; tgt $17
- Natera (NTRA) initiated with an Outperform at Credit Suisse; tgt $70
- NICE (NICE) initiated with a Neutral at Piper Sandler; tgt $236
- NOV Inc. (NOV) initiated with a Hold at The Benchmark Company
- NuScale Power (SMR) initiated with an Equal Weight at Wells Fargo; tgt $17
- PerkinElmer (PKI) initiated with a Neutral at Credit Suisse; tgt $175
- Protagonist Therapeutics (PTGX) initiated with a Mkt Outperform at JMP Securities; tgt $21
- Satsuma Pharmaceuticals (STSA) initiated with a Buy at JonesTrading; tgt $14
- TechnipFMC (FTI) initiated with a Buy at The Benchmark Company; tgt $12
- Thermo Fisher (TMO) initiated with a Neutral at Credit Suisse; tgt $675
- Waters (WAT) initiated with a Neutral at Credit Suisse; tgt $345